Navigation Links
Report focuses on the role good microbes play in future medicine

Not all bacteria are bad. In fact, beneficial microbes could represent the future of medicine, with the potential to treat a variety of diseases in humans and animals from diarrhea and eczema to gum disease and autoimmune disorders, according to a report released by the American Academy of Microbiology, Probiotic Microbes: The Scientific Basis.

"Theoretically, beneficial microorganisms could be used to treat a range of clinical conditions that have been linked to pathogens, including gastrointestinal problems like irritable bowel syndrome and inflammatory bowel disease, oral diseases like tooth decay and periodontal disease, and various other infections, including vaginal infections and possibly skin infections. Probiotics could also conceivably be put to use in preventing disease or thwarting autoimmune disorders. A number of these possibilities are being explored in research labs and hospitals around the world," says Richard Walker of the Food and Drug Administration, a co-chair of the steering committee that produced the report.

Probiotics can help prevent and treat disease through a number of mechanisms. One way is by interacting directly with the disease-causing microbes, making it harder for them to cause disease. An example of this is the ingestion of probiotic bacteria to prevent or treat diarrhea. The organisms help reinforce the natural bacterial barrier that exists on the lining of the digestive tract providing additional protection against pathogenic organisms that can cause diarrhea.

"Several probiotics have been shown to shorten the duration of acute watery diarrhea caused by rotavirus in children. Other causes of diarrhea may also be addressed through probiotics," says Carol Wells of the University of Minnesota, a member of the steering committee.

Another example of microbe-microbe interaction in probiotics is a phenomenon known as "competitive exclusion" in which beneficial microbes directly compete with disease
'"/>

Source:American Society for Microbiology


Page: 1 2

Related biology news :

1. Report that delayed motherhood decreases life expectancy of mouse offspring
2. AIDS Public Awareness Campaign Expands Following Report Of Rapidly Progressive HIV
3. Report focuses on challenges to unlocking future promise of vaccines
4. Report finds cruise industry is protecting the precious places it visits
5. Report shows deforestation threatens Brazils Pantanal
6. Report lists top 20 most-vulnerable African carnivores
7. Report warns about carbon dioxide threats to marine life
8. Report highlights change in Canadas forests
9. Report calls for improved monoclonal antibodies against solid tumors
10. Study of energy and health in Africa focuses spotlight on charcoal and forest management
11. W.M. Keck Foundation funds study of friendly microbes

Post Your Comments:
(Date:11/23/2009)... , DURHAM, N.H. University of New Hampshire mi...taling $498,115 to advance understanding of the ac...tential to enrich nutrient-poor and contaminated s...ture (USDA) awarded Tisa, a professor of molecular...plore the symbiotic relationship between the bacte...
(Date:11/23/2009)... , , University of Southern California biomedical...s to develop a new tool to help clinicians disting...ry from chronic problems manageable with drugs and...catheters inserted into the arteries feeding the h... ("lumen") of these blood vessels, often revealing...
(Date:11/23/2009)... , Amphibians like frogs and toads have existed f...rs didn,t, but a new aquatic fungus is threatening...icle in the November issue of Microbiology Today ... (Bd), was found to be associated with waves of a...eastern Australia in the 1990,s. Bd infects over 3...
Breaking Biology News(10 mins):UNH prof. receives nearly $500,000 to research environmentally significant plants 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2H D Smith Promotes Leadership to Fill Two Senior Roles 51210 1H D Smith Promotes Leadership to Fill Two Senior Roles 51210 2ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 1ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 2ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 3ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 4ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 5Study identifies potential fix for damaged knees 51203 1Study identifies potential fix for damaged knees 51203 2Study identifies potential fix for damaged knees 51203 3
...ngineers at MIT are developing a tiny sensor that ...dous gases, including toxic industrial chemicals a... current devices. , The researchers have taken th... spectrometry and shrunk them to fit in a device t... led by MIT Professor Akintunde Ibitayo Akinwande,...
...tes Xie Lab has published findings that begin to c...g stem cells within their cellular microenvironme...ays issue of Cell Stem Cell. , The Xie Lab demon...ovarian germline stem cells (GSCs), behaving like ...em cells for a position in the niche. They do so b...
... NY Cold Spring Harbor Laboratorys (CSHL) researc... by Joans Legacy: The Joan Scarangello Foundation ...nd CSHLs pioneering lung cancer research involving...e a trigger in non-small cell lung cancer, the lea..., The mutations, called epidermal growth factor r...
Other Biology News:MIT gas sensor is tiny, quick 2Cold Spring Harbor Laboratory's lung cancer research program awarded $100,000 grant 2
(Date:11/24/2009)...November24/PRNewswire-FirstCall/--deCODE,genetics,...noticefrom,theNasdaqStockMarketthattradinginthecom...09andaForm25-NSEwillbefiledwiththe,SecuritiesandEx...k,fromlistingonNasdaq,unlessthecompanyfilesanappea...hasfiledsuchanappeal,which,willstaythesuspensionan...
(Date:11/24/2009)...Newswire-Asia/--NODPharmaceuticalsInc.announced,th...entapplicationfor,itsnano-particleoraldeliveryorNO...tapproachtoincorporatepeptidesor,proteinsintobio-a...therwiseadministeredasinjections.NODtechnologyisap...ulardrugssuchasinsulin,interferon,growthhormone,e...
(Date:11/24/2009)...The FBI recently approved the Promega PowerPlex 16...n or generating DNA records for the National DNA I...I USA (PRWEB) -- The FBI recently approved the Pro...ratories participating in, or generating DNA recor... currently contains more than seven million profil...
(Date:11/24/2009)...09/PRNewswire-FirstCall/--ArenaPharmaceuticals,Inc...heduledtopresentatthePiperJaffray21stAnnualHealthC...e(8:30a.m.PacificTime)attheNewYorkPalaceHotelinNew...iveOfficer,isscheduledtoprovideanoverviewofthecomp...grams. ,, Aliveaudiowebcastofthepresentationwil...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...ransfer Paves the Way for the Phase III Clinical D...00 in Developing Countries, LEUVEN, Belgium, Sept..., a biotechnology company focused on vascular dise...the technology transfer to Bharat,Biotech Internat...re of,THR-100, a novel variant of Recombinant Stap...
...EIJING, Sept. 3 /Xinhua-PRNewswire-FirstCall/ -- C...asdaq: CMED ), a leading China-based,medical devi... advanced in-,vitro diagnostic products and high i... today announced that it will participate in Credi...a Day. Location: Shenzhen, China Date:...
...ARIS, September 2 Sanofi-aventis announced,today ...IMI 25 and STEEPLE,studies confirm clear net clini...vation myocardial infarction (STEMI) for Lovenox(R...IMI 25 and STEEPLE one year results were presented...f Cardiology (ESC) Congress in,Vienna, Austria. E...
Other Biology Technology:ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 2ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 3ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 4New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome 2New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome 3New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome 4New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome 5
...D.471. Immunogen: Synthetic peptide derived from ...Specificity: Specific for the junctophilin-1 prote...rain and skeletal muscle homogenates frozen mouse ... Western blotting Immunohistochemistry(froz) Immun...
Mouse Anti-Human Laminin beta-1 / gamma-1 complex Monoclonal Antibody, Unconjugated, Clone 612C10 from Santa Cruz Biotechnology, Inc.
Rabbit Anti-JIP 1 Polyclonal Antibody, Unconjugated from BioVision
Mouse Anti-Mouse XBP-1 Monoclonal Antibody, Unconjugated, Clone F-4 from Santa Cruz Biotechnology, Inc.
Biology Products: